… One large, multi-center study examining the efficacy of this device on non-genital warts of
up to 10 × 10 mm in size is underway at the time of writing this article. Interim results of 96 …

… Since then, new pharmacological agents and methods have broadened the spectrum of …
genital warts currently available and to translate the significance/usefulness of novel treatment …

… A recent study estimated that the direct cost of genital wart management in the United
Kingdom (UK) in 2012 was £58.44 million.11 The main drivers of cost were disease recurrence, …

… , but there is no evidence that high risk HPV types cause genital warts. Anogenital … The
negative impact of genital warts on sexual activity and health related quality of life outcomes is …

… A new approach to treating warts involves induction or boosting of an immune response.
Given the systemic effects of the immune response triggered, immunotherapy frequently also …

… their patients had genital lesions; they considered as a whole the 128 warts of their … warts.
They observed complete resolution in all (100%) the treated genital warts after four treatment …

… In this study, we systematically reviewed all topically applied treatment options for
external genital warts that were studied in at least one RCT and met our eligibility criteria. …

… that called anogenital warts (AGW) (genital warts, condyloma acuminate, condylomas) (2,3)
(Figures 1-3). There are more than 200 hundred variants of HPV (4). HPV is divided into two …

… Topical treatments of warts increase local production of interferon and decrease viral load
of human papiloma virus (HPV). The surgical methods for genital warts include curettage, …

… Anogenital warts (AGWs) are benign epithelial skin lesions that are predominantly caused
… (HPV types 6 and 11), but are sometimes associated with other types of oncogenic HPV [1]. …